JEMPERLI 500 mg concentrate for solution for infusion, Zejula 100 mg film-coated tablets, Zejula 100 mg film-coated tablets
Phase 2 small_molecule active
Quick answer
JEMPERLI 500 mg concentrate for solution for infusion, Zejula 100 mg film-coated tablets, Zejula 100 mg film-coated tablets for HPV-negative Head and Neck Squamous Cell Carcinoma (HNSCC) is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- HPV-negative Head and Neck Squamous Cell Carcinoma (HNSCC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active